MAPT and Alzheimer disease: Our key finding of higher GAP-43 being related to accelerated tau accumulation in AD supports a mechanistic model of AD pathophysiology in which synaptic changes are critically involved in the Aβ-associated spreading of tau pathology, i.e., the key driver of neurodegeneration and cognitive decline in AD2,26,27.